A detailed history of Carnegie Capital Asset Management, LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Carnegie Capital Asset Management, LLC holds 156,576 shares of ZTS stock, worth $27.7 Million. This represents 0.92% of its overall portfolio holdings.

Number of Shares
156,576
Previous 157,577 0.64%
Holding current value
$27.7 Million
Previous $27.3 Million 11.99%
% of portfolio
0.92%
Previous 0.86%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

SELL
$172.58 - $196.48 $172,752 - $196,676
-1,001 Reduced 0.64%
156,576 $30.6 Million
Q2 2024

Jul 19, 2024

SELL
$145.54 - $178.83 $3.25 Million - $3.99 Million
-22,316 Reduced 12.41%
157,577 $27.3 Million
Q1 2024

May 03, 2024

BUY
$165.67 - $199.94 $966,353 - $1.17 Million
5,833 Added 3.35%
179,893 $30.4 Million
Q4 2023

Jan 29, 2024

BUY
$151.44 - $200.09 $231,248 - $305,537
1,527 Added 0.89%
174,060 $34.4 Million
Q3 2023

Oct 10, 2023

BUY
$167.14 - $192.77 $1.09 Million - $1.26 Million
6,540 Added 3.94%
172,533 $30 Million
Q2 2023

Aug 04, 2023

BUY
$160.94 - $186.23 $464,794 - $537,832
2,888 Added 1.77%
165,993 $28.6 Million
Q1 2023

Apr 19, 2023

BUY
$145.48 - $175.02 $405,307 - $487,605
2,786 Added 1.74%
163,105 $27.1 Million
Q4 2022

Jan 23, 2023

BUY
$131.14 - $157.47 $658,322 - $790,499
5,020 Added 3.23%
160,319 $0
Q3 2022

Oct 13, 2022

SELL
$148.29 - $182.55 $392,968 - $483,757
-2,650 Reduced 1.68%
155,299 $23 Million
Q2 2022

Aug 02, 2022

SELL
$155.97 - $200.09 $903,222 - $1.16 Million
-5,791 Reduced 3.54%
157,949 $27.2 Million
Q2 2022

Jul 13, 2022

BUY
$155.97 - $200.09 $166,264 - $213,295
1,066 Added 0.66%
163,740 $30.5 Million
Q1 2022

Apr 11, 2022

BUY
$181.39 - $234.03 $82,532 - $106,483
455 Added 0.28%
162,674 $30.7 Million
Q4 2021

Jan 21, 2022

BUY
$193.69 - $247.03 $6,779 - $8,646
35 Added 0.02%
162,219 $39.6 Million
Q3 2021

Oct 08, 2021

SELL
$189.29 - $209.69 $294,535 - $326,277
-1,556 Reduced 0.95%
162,184 $31.5 Million
Q2 2021

Jul 16, 2021

SELL
$155.9 - $187.99 $778,408 - $938,634
-4,993 Reduced 2.96%
163,740 $30.5 Million
Q1 2021

Apr 12, 2021

BUY
$144.0 - $169.39 $517,248 - $608,448
3,592 Added 2.18%
168,733 $26.6 Million
Q4 2020

Feb 08, 2021

BUY
$157.07 - $174.35 $836,397 - $928,413
5,325 Added 3.33%
165,141 $27.3 Million
Q3 2020

Oct 13, 2020

BUY
$137.1 - $165.37 $644,370 - $777,239
4,700 Added 3.03%
159,816 $26.4 Million
Q2 2020

Jul 09, 2020

SELL
$111.92 - $142.53 $27,420 - $34,919
-245 Reduced 0.16%
155,116 $21.2 Million
Q1 2020

May 08, 2020

SELL
$92.66 - $144.94 $215,897 - $337,710
-2,330 Reduced 1.48%
155,361 $18.2 Million
Q4 2019

Feb 13, 2020

SELL
$116.25 - $133.25 $113,111 - $129,652
-973 Reduced 0.61%
157,691 $20.9 Million
Q3 2019

Nov 20, 2019

SELL
$112.57 - $128.43 $222,325 - $253,649
-1,975 Reduced 1.23%
158,664 $19.8 Million
Q2 2019

Jul 24, 2019

SELL
$97.98 - $114.28 $94,256 - $109,937
-962 Reduced 0.6%
160,639 $18.2 Million
Q1 2019

May 14, 2019

SELL
$81.56 - $100.67 $432,512 - $533,853
-5,303 Reduced 3.18%
161,601 $16.3 Million
Q4 2018

Feb 14, 2019

SELL
$79.28 - $95.27 $4.74 Million - $5.69 Million
-59,767 Reduced 26.37%
166,904 $14.3 Million
Q3 2018

Nov 27, 2018

BUY
$83.5 - $93.23 $4.9 Million - $5.47 Million
58,663 Added 34.92%
226,671 $20.9 Million
Q2 2018

Aug 16, 2018

BUY
$79.9 - $89.2 $292,993 - $327,096
3,667 Added 2.23%
168,008 $15.4 Million
Q1 2018

May 15, 2018

SELL
$71.51 - $84.69 $141,804 - $167,940
-1,983 Reduced 1.19%
164,341 $13.9 Million
Q4 2017

Feb 12, 2018

SELL
$63.24 - $72.8 $178,147 - $205,077
-2,817 Reduced 1.67%
166,324 $12.3 Million
Q3 2017

Nov 14, 2017

SELL
$59.73 - $65.4 $126,627 - $138,648
-2,120 Reduced 1.24%
169,141 $11 Million
Q2 2017

Aug 14, 2017

BUY
N/A
171,261
171,261 $10.5 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.8B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Carnegie Capital Asset Management, LLC Portfolio

Follow Carnegie Capital Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Carnegie Capital Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Carnegie Capital Asset Management, LLC with notifications on news.